Enterprise Value
-78.01M
Cash
159M
Avg Qtr Burn
-16.1M
Short % of Float
2.14%
Insider Ownership
6.65%
Institutional Own.
47.82%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TEMBEXA (brincidofovir) Details Smallpox | Approved Quarterly sales | |
ONC201 Details Glioma, Cancer, Brain tumor | Phase 3 Data readout | |
ONC206 Details Solid tumor/s, Brain tumor, Glioblastoma | Phase 1 Data readout | |
Dociparstat sodium (DSTAT) Details Cancer, Acute myeloid leukemia | Failed Discontinued | |
Dociparstat sodium (DSTAT) Details Infectious disease, COVID-19 | Failed Discontinued |